1. Define antiviral resistance and explain what may lead a health care provider to believe that resistance to antiviral therapy is occurring? 2. Define antiviral susceptibility testing and list some of the factors that may vary the end results of testing. 3. Explain the lack of standardization of protocols for antiviral susceptibility testing. 4. Define the criteria that determine whether antiviral susceptibility testing should be performed. 5. Explain the difference between phenotypic and genotypic antiviral susceptibility testing. 6. Name some of the types of phenotypic susceptibility testing and list some of the advantages and disadvantages of this method of susceptibility testing. 7. Describe the methodology of genotypic susceptibility testing and list some of the illnesses for which it is used. 8. List the reasons for drug susceptibility testing for individuals infected with the human immunodeficiency virus (HIV). 9. List the vaccinations used to prevent influenza infection. Also, explain why this vaccine must be reformulated every year and why ongoing surveillance of influenza isolates is crucial to the global vaccination program. 10. Name the two classes of antiviral medications used to treat and prevent influenza. Also, list the four antiviral medications that have been approved by the U.S. Food and Drug Administration (FDA) and briefly explain their mode of action.
Antiviral Therapy, Susceptibility Testing, and Prevention
Methods of Antiviral Susceptibility Testing
Human Immunodeficiency Virus
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
Antiviral Therapy, Susceptibility Testing, and Prevention
![](https://clinicalpub.com/wp-content/uploads/2023/09/banner1.png)